| Home : March 2021 : March 05, 2021 News : Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy |
Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy |
March 05, 2021
STOCKHOLM, March 5, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest solution for proton therapy, Monaco®* treatment planning for protons, has received 510(k) clearance from the U.S. Food and Drug Administration. Monaco brings robust functionality for proton...
https://www.prnewswire.com:443/news-releases/elekta-and-iba-strengthen-partnership-to-help-cancer-centers-integrate-proton-therapy-301241282.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
